glp-1 microdosing research GLP-1s: Does It Work? Risks and Benefits Microdosing GLP-1 Drugs: What To

This phenomenon isnt unique to one state

doi: 10.1002/bdrb.20056 69 AndersonGDAhokasRALipshitzJDiltsPVJr

Ozempic, Wegovy, and compounded semaglutide target the glucagon-like peptide-1 receptornot thyroid-stimulating hormone or thyroid peroxidase

Compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA Compounded Semaglutide (GLP-1) Injections A once-weekly GLP-1 injection designed to help reduce appetite, improve metabolic health, and support sustainable weight loss under licensed medical supervision

Large meals, fried foods, alcohol, and spicy foods can make these symptoms worse, while smaller portions and simpler, easy-to-digest meals are often better tolerated

In January 2025, the FDA approved an injectable form of semaglutide (Ozempic) specifically for managing chronic kidney disease in type 2 diabetes patients